Cellular proliferation and macrophage influx precede interstitial fibrosis in cyclosporine nephrotoxicity

B A Young1, E A Burdmann, R J Johnson

  • 1Department of Medicine, University of Washington, Seattle, USA.

Kidney International
|August 1, 1995
PubMed

Insights

Chronic cyclosporine (CsA) nephrotoxicity involves early cell proliferation and macrophage influx, preceding fibrosis and functional decline in kidney transplant patients. These changes are key to understanding CsA-induced kidney damage.

Area of Science:

  • Nephrology
  • Transplantation Medicine
  • Pathology

Background:

  • Chronic cyclosporine (CsA) nephrotoxicity is a significant complication following solid organ transplantation.
  • Histological features include tubulointerstitial fibrosis, tubular atrophy, and afferent arteriole hyalinization.
  • The salt-depleted rat model accurately replicates human CsA nephropathy lesions.

Purpose of the Study:

  • To investigate the sequential cellular and functional changes in a rat model of chronic CsA nephropathy.
  • To elucidate the early events contributing to the pathogenesis of CsA-induced kidney injury.

Main Methods:

  • Sequential studies were conducted on salt-depleted rats treated with CsA or olive oil.
  • Cell proliferation, macrophage infiltration, collagen deposition, and vimentin expression were assessed.
  • Renal function (serum creatinine, concentrating ability, urinary volume) and blood pressure were monitored.

Main Results:

  • Early tubular and interstitial cell proliferation was observed by day 5, peaking by day 35.
  • Significant macrophage influx correlated with interstitial fibrosis and osteopontin expression.
  • Elevated serum creatinine correlated with interstitial fibrosis; functional deficits stabilized despite fibrosis.

Conclusions:

  • CsA nephrotoxicity involves early cell proliferation and macrophage influx preceding fibrosis and arteriolar hyalinosis.
  • These cellular events correlate with functional abnormalities like reduced creatinine clearance and concentrating ability.
  • The intrarenal renin-angiotensin system may play a role in CsA-induced kidney disease.

Related Concept Videos

Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...